The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease

被引:50
|
作者
Groblewska, Magdalena [1 ]
Muszynski, Pawel [2 ]
Wojtulewska-Supron, Aleksandra [3 ]
Kulczynska-Przybik, Agnieszka [2 ]
Mroczko, Barbara [1 ,2 ]
机构
[1] Univ Hosp, Dept Biochem Diagnost, Bialystok, Poland
[2] Med Univ Bialystok, Dept Neurodegenerat Diagnost, PL-15269 Bialystok, Poland
[3] Med Univ Bialystok, Dept Psychiat, PL-15269 Bialystok, Poland
关键词
Alzheimer's disease; biomarkers; brain injury; neurodegeneration; visinin-like protein-1; CALCIUM SENSOR PROTEINS; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; SYNAPTIC PLASTICITY; SUBCELLULAR-LOCALIZATION; MEMBRANE ASSOCIATION; CEREBROSPINAL-FLUID; NEUROCALCIN-DELTA; CORTICAL-NEURONS; BINDING PROTEINS;
D O I
10.3233/JAD-150060
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Calcium ions are crucial in the process of information transmission and integration in the central nervous system (CNS). These ions participate not only in intracellular mechanisms but also in intercellular processes. The changes in the concentration of Ca2+ ions modulate synaptic transmission, whereas neuronal activity induces calcium ion waves. Disturbed calcium homeostasis is thought to be one of the main features in the pathophysiology of Alzheimer's disease (AD), and AD pathogenesis is closely connected to Ca2+ signaling pathways. The effects of changes in neuronal Ca2+ are mediated by neuronal calcium sensor (NCS) proteins. It has been revealed that NCS proteins, with special attention to visinin-like protein 1 (VILIP-1), might have a connection to the etiology of AD. In the CNS, VILIP-1 influences the intracellular neuronal signaling pathways involved in synaptic plasticity, such as cyclic nucleotide cascades and nicotinergic signaling. This particular protein is implicated in calcium-mediated neuronal injury as well. VILIP-1 also participates in the pathological mechanisms of altered Ca2+ homeostasis, leading to neuronal loss. These findings confirm the utility of VILIP-1 as a useful biomarker of neuronal injury. Moreover, VILIP-1 plays a vital role in linking calcium-mediated neurotoxicity and AD-type pathological changes. The disruption of Ca2+ homeostasis caused by AD-type neurodegeneration may result in the damage of VILIP-1-containing neurons in the brain, leading to increased cerebrospinal fluid levels of VILIP-1. Thus, the aim of this overview is to describe the relationships of the NCS protein VILIP-1 with the pathogenetic factors of AD and neurodegenerative processes, as well as its potential clinical usefulness as a biomarker of AD. Moreover, we describe the current and probable therapeutic strategies for AD, targeting calcium-signaling pathways and VILIP-1.
引用
收藏
页码:17 / 32
页数:16
相关论文
共 50 条
  • [1] THE USEFULNESS OF VISININ-LIKE PROTEIN 1 AS A POTENTIAL BIOMARKER IN ALZHEIMER'S DISEASE
    Mroczko, B.
    Kulczynska-Przybik, A.
    Lukaszewicz-Zajac, M.
    Kornhuber, J.
    Lewczuk, P.
    DRUGS OF THE FUTURE, 2015, 40 (11) : 751 - 756
  • [2] Visinin-like Protein-1: Diagnostic and Prognostic Biomarker in Alzheimer Disease
    Tarawneh, Rawan
    D'Angelo, Gina
    Macy, Elizabeth
    Xiong, Chengjie
    Carter, Deborah
    Cairns, Nigel J.
    Fagan, Anne M.
    Head, Denise
    Mintun, Mark A.
    Ladenson, Jack H.
    Lee, Jin-Moo
    Morris, John C.
    Holtzman, David M.
    ANNALS OF NEUROLOGY, 2011, 70 (02) : 274 - 285
  • [3] CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies
    Luo, Xinni
    Hou, Le
    Shi, Haishan
    Zhong, Xiaomei
    Zhang, Yufeng
    Zheng, Dong
    Tan, Yan
    Hu, Guoyan
    Mu, Nan
    Chan, Jianping
    Chen, Xinru
    Fang, Yaxiu
    Wu, Fengchun
    He, Hongbo
    Ning, Yuping
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (05) : 681 - 690
  • [4] Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease
    Mroczko, Barbara
    Groblewska, Magdalena
    Zboch, Marzena
    Muszynski, Pawel
    Zajkowska, Agata
    Borawska, Renata
    Szmitkowski, Maciej
    Kornhuber, Johannes
    Lewczuk, Piotr
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 43 (03) : 1031 - 1037
  • [5] Serum visinin-like protein-1 in concussed professional ice hockey players
    Shahim, Pashtun
    Mattsson, Niklas
    Macy, Elizabeth M.
    Crimmins, Dan L.
    Ladenson, Jack H.
    Zetterberg, Henrik
    Blennow, Kaj
    Tegner, Yelverton
    BRAIN INJURY, 2015, 29 (7-8) : 872 - 876
  • [6] Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease
    Zhang, Hua
    Ng, Kok Pin
    Therriault, Joseph
    Kang, Min Su
    Pascoal, Tharick A.
    Rosa-Neto, Pedro
    Gauthier, Serge
    TRANSLATIONAL NEURODEGENERATION, 2018, 7 (01):
  • [7] Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
    Hua Zhang
    Kok Pin Ng
    Joseph Therriault
    Min Su Kang
    Tharick A. Pascoal
    Pedro Rosa-Neto
    Serge Gauthier
    Translational Neurodegeneration, 7
  • [8] Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment
    Leko, Mirjana Babic
    Borovecki, Fran
    Dejanovic, Nenad
    Hof, Patrick R.
    Simic, Goran
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (03) : 765 - 778
  • [9] Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseases
    Halbgebauer, Steffen
    Steinacker, Petra
    Riedel, Daniel
    Oeckl, Patrick
    Anderl-Straub, Sarah
    Lombardi, Jolina
    von Arnim, Christine A. F.
    Nagl, Magdalena
    Giese, Armin
    Ludolph, Albert C.
    Otto, Markus
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [10] Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration
    Kirkwood, Caitlin M.
    MacDonald, Matthew L.
    Schempf, Tadhg A.
    Vatsavayi, Anil V.
    Ikonomovic, Milos D.
    Koppel, Jeremy L.
    Ding, Ying
    Sun, Mai
    Kofler, Julia K.
    Lopez, Oscar L.
    Yates, Nathan A.
    Sweet, Robert A.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (02) : 175 - 182